Guangzhou Da An Gene Co., Ltd. announces that its wholly-owned subsidiary, Guangzhou Datase Bio-engineering Technology Co., Ltd., has obtained a medical device registration certificate from the National Medical Products Administration for its Alpha-fetoprotein (AFP) assay kit (chemiluminescence immunoassay). The product is for in vitro quantitative determination of AFP in serum or plasma, primarily for monitoring primary liver cancer treatment. The company notes that market development for this product is ongoing and subject to market demand uncertainties.
Summary generated by AI · Always verify with source document
Guangzhou Da An Gene Co., Ltd.
Announcement on Subsidiary Obtaining a Medical Device Registration Certificate
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Recently, Guangzhou Datase Bio-engineering Technology Co., Ltd., a wholly-owned subsidiary of the Company, obtained a medical device registration certific
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.